Skip to content
Lower risk Drug recall · FDA · Published July 31, 2026

Liebel-Flarsheim Optiray Imaging Bulk Package-350 Recall: Particulate Matter Hazard

Liebel-Flarsheim recalls Optiray Imaging Bulk Package-350 (Ioversol 74%) due to potential particulate matter in the injection solution. This could cause blockages or reactions if injected. Affected units have NDC 0019-1333-65 and lot # 25ZF3670.

🇺🇸 FDA recall #D-0773-2026DrugLiebel-Flarsheim ›
✎ GovInfoNow plain-language explainer

Liebel-Flarsheim is recalling Optiray Imaging Bulk Package-350 (Ioversol 74%) injections because they may contain plastic, metal, and glass particles. This could cause blockages or reactions if injected into the body. The recall affects medical facilities using this product for imaging procedures. Read more at govinfonow.com/recall/454404-liebel-flarsheim-optiray-imaging-bulk-package-350-recall-particulate-matter.

Source Summary by GovInfoNow · govinfonow.com/recall/454404-liebel-flarsheim-optiray-imaging-bulk-package-350-recall-particulate-matter · Updated August 27, 2026 · FDA enforcement record: FDA #D-0773-2026

Cite this page

“Liebel-Flarsheim Optiray Imaging Bulk Package-350 Recall: Particulate Matter Hazard.” GovInfoNow, updated August 27, 2026. https://govinfonow.com/recall/454404-liebel-flarsheim-optiray-imaging-bulk-package-350-recall-particulate-matter. Based on FDA recall #D-0773-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0773-2026%22&limit=1).

The FDA announced on July 31, 2026, that Liebel-Flarsheim Company LLC is recalling Optiray Imaging Bulk Package-350 due to the presence of particulate matter. The Class I recall affects 3,486 multiple-dose vials distributed nationwide.

How to tell if you have it

  • Brand: Liebel-Flarsheim
  • Product: Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial
  • NDC: 0019-1333-65
  • Lot #: 25ZF3670
  • Expiration Date: May 31, 2027
  • Quantity: 3,486 units

The hazard

The recall is due to the presence of particulate matter comprising polyethylene, other plastic materials, stainless steel, and glass. The FDA classified this as a Class I hazard.

Context

GovInfoNow's records show Liebel-Flarsheim Company LLC has one other recall on record since March 11, 2021, involving the HydraVision Digital Imaging System. Other recent recalls of similar products include B. Braun Medical Lactated Ringer's Injection Recall (August 12, 2026), GE Healthcare Omnipaque 300 mg/mL Injection Recall (March 24, 2026), and GE Healthcare Omnipaque Injection Recall (March 24, 2026).

How to tell if you have this one

Check for the product name 'Optiray Imaging Bulk Package-350' with NDC 0019-1333-65 and lot number 25ZF3670. The product is a 500 mL multiple-dose vial for medical imaging procedures.

  • Brand
    Liebel-Flarsheim
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC code 0019-1333-65 and lot number 25ZF3670 on the vial label.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the US and Mexico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 19 days after the firm started it.

1. Firm started the recall: Jul 31, 202612. FDA classified it Class I: Aug 19, 202623. Published in FDA’s Enforcement Report: Aug 19, 202634. Added to GovInfoNow: Aug 27, 202642026
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates potential particulate matter, but the product is still safe for use if the particulate matter is not present. The manufacturer recommends checking the lot number and NDC code.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0773-2026 (July 31, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0773-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 27, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA